We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
HOW KETAMINE BECAME AN ANTIDEPRESSANT.
- Authors
Joralemon, Vincent
- Abstract
The article provides an in-depth exploration of the journey of ketamine from an anesthetic to a groundbreaking treatment for depression. It traces the history of depression therapies in the U.S., from traditional approaches to modern pharmacological interventions like selective serotonin reuptake inhibitors (SSRIs). It discusses the challenges related to intellectual property, regulatory approval, and insurance coverage that have impacted the wider adoption of ketamine for depression treatment.
- Subjects
KETAMINE; MENTAL depression; SEROTONIN uptake inhibitors; INTELLECTUAL property; INSURANCE
- Publication
Berkeley Technology Law Journal, 2024, Vol 39, p497
- ISSN
1086-3818
- Publication type
Article
- DOI
10.15779/Z38W08WH8B